According to a recent market study published by Growth Market Reports titled, “Global Ibuprofen Market by Type, Dosage Form, and Region: Size, Share, Trends, and Opportunity Analysis, 2017-2027”, the market was valued at USD 1,146.2 Million in 2019 and is estimated to expand at a CAGR of 2.7% during 2020 and 2027. The global ibuprofen market is anticipated to grow owing to increasing number of patients with arthritis. Moreover, the ability of ibuprofen for treating a wide range of aches and pains such as joints pain, back pain, period pain, and toothache is further expected to boost the growth of the market. Ibuprofen is also used in the treatment of puncture wounds and inflammations such as strains and sprains.

The global ibuprofen market is fragmented based on types, dosage forms, and regions. In terms of types, the market is segmented into USP and EP. On the basis of dosage forms, the market is divided into tablet, capsule, suspension, and others. Based on regions, the global ibuprofen market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa (MEA).

North America is bifurcated into countries such as U.S., and Canada. Europe is categorized into Germany, France, Italy, the U.K., Spain, Russia, and Rest of Europe. Asia Pacific is sub-segmented into China, Japan, South Korea, India, Australia, South East Asia (SEA), and Rest of Asia Pacific (APAC). Latin America is segregated into Brazil, Mexico, and Rest of Latin America (LATAM), and the Middle East & Africa is divided into Saudi Arabia, South Africa, the UAE, and Rest of Middle East & Africa (MEA).

Request a free sample copy:

In 2020, the ibuprofen market is expected to witness a significant growth in lieu of COVID-19 pandemic. Various medical research institute and vaccine manufacturing are trying to find the possible usage of ibuprofen drug for the development of COVID-19 vaccine or treatment. Moreover, prevalence of depression symptoms among adults in several regions due to the outbreak of coronavirus is further expected to boost the market.

As per Growth Market Reports industry analyst Akshata Ahire, “The Global Ibuprofen Market is anticipated to witness significant growth during forecast period 2020-2027 driven by growing focus continuous rising cases of gouty arthritis, ankylosing spondylitis, and psoriatic arthritis (arthritis that occurs with a long-lasting skin disease that causes scaling and swelling, which are mainly treated with the help of ibuprofen. Key players in the market are actively focusing on R&D activities for improving the dosage of ibuprofen.”

Key Takeaways from the Study

  • Germany based BASE SE, is expected to hold more than one sixth of market share of the global ibuprofen market in 2020.
  • North America accounts for a major share of the market, followed by Europe and Asia Pacific. The ibuprofen market in North America is projected to expand at significant CAGR during the forecast period.
  • In terms of value, the tablet segment is anticipated to hold a major share of the global market during the forecast period. The segment is further expected expand at a significant CAGR during the forecast period. The growth is attributed to the introduction of flavored chewable tablets for children as well as adults.
  • The USP segment is anticipated to expand at a substantial CAGR during the forecast period due to increasing number of mild diseases in the North America region.

Report Scope

Report Metric


Market Value in 2019

USD 1,436.8 Million

Market Growth Rate (from 2021 to 2027)


Historical Data

2017 & 2018

Base Year


Forecast Period

2020 - 2027

Units Considered

Value (USD Million)

Market Segments

Types, Dosage Forms

Regional Scope

North America, Europe, Latin America, Asia Pacific, Middle East & Africa (MEA)

Country Scope

The U.S., Canada, Germany, France, Italy, the U.K., Spain, Russia, Rest of Europe, China, Japan, South Korea, India, Australia, South East Asia (SEA), Rest of Asia Pacific (APAC), Brazil, Mexico, Rest of Latin America (LATAM), Saudi Arabia, South Africa, the UAE, and Rest of Middle East & Africa (MEA)

Key Companies Profiled

BASF SE, Granules India Limited (Granules Biocause), IOL Chemicals And Pharmaceuticals Limited., SI Group, Inc., Strides Pharma Science Limited., Xinhua Pharm, and Zhejiang Hisoar Pharmaceutical Co.,LTD.

Customization Scope

Report customization available on request

Pricing and Purchase Options

Avail tailor-made purchase options to meet your research requirements.

Target Audience

  • Supply-Side: Ibuprofen Manufacturers (Pharmaceutical Companies), Raw Material Suppliers, Primary Respondents, and Distributors.
  • Demand Side: Hospitals, Clinics, Homecare, Pharmacies, Drug Stores, Group Purchasing Organizations, and Medical Payers
  • Regulatory Side: Concerned Government Authorities, Commercial Research & Development (R&D) Institutions, and Other Regulatory Bodies
  • Associations and Industry Bodies: Centers for Disease Control and Prevention (CDC), National Institute of Allergy and Infectious Diseases (NIAID), Food and Drug Administration (FDA), World Health Organization (WHO), Medicines and Healthcare Products Regulatory Agency (MHRA), Therapeutic Goods Administration (TGA), Central Drug Standard Control Organization (CDSCO), Ministry of Health, Labor and Welfare (MHLW), International Federation of Pharmaceutical Manufacturers & Association (IFPMA), World Trade Organization (WTO), Indian Medical Research Council (ICMR).